The CBP/p300 histone acetyltransferases function as plant-specific MEDIATOR subunits in Arabidopsis

来源 :植物学报(英文版) | 被引量 : 0次 | 上传用户:kingerfly
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
In eukaryotes, MEDIATOR is a conserved multi-subunit complex that links transcription factors and RNA polymerase Ⅱ and that thereby facilitates transcriptional initiation. Although the composi-tion of MEDIATOR has been well studied in yeast and mammals, relatively little is known about the composition of MEDIATOR in plants. By affinity purification followed by mass spectrometry, we identified 28 conserved MEDIATOR subunits in Arabidopsis thaliana, including putative MEDI-ATOR subunits that were not previously validated. Our results indicated that MED34, MED35, MED36, and MED37 are not Arabidopsis MEDI-ATOR subunits, as previously proposed. Our re-sults also revealed that two homologous CBP/p300 histone acetyltransferases, HAC1 and HAC5 (HAC1/5) are in fact plant-specific MEDIATOR subunits. The MEDIATOR subunits MED8 and MED25 (MED8/25) are partially responsible for the association of MEDIATOR with HAC1/5, MED8/25 and HAC1/5 co-regulate gene expression and thereby affect flowering time and floral develop-ment. Our in vitro observations indicated that MED8 and HAC1 form liquid-like droplets by phase separation, and our in vivo observations indicated that these droplets co-localize in the nuclear bodies at a subset of nuclei. The formation of liquid-like droplets is required for MED8 to in-teract with RNA polymerase Ⅱ. In summary, we have identified all of the components of Arabi-dopsis MEDIATOR and revealed the mechanism underlying the link of histone acetylation and transcriptional regulation.
其他文献
目的:分析经皮肾镜碎石术治疗复杂性肾结石的临床疗效及对患者肾功能的影响.方法:选择我院接受治疗的64例复杂性肾结石患者,分为两组,各32例,甲组采取经皮肾镜碎石术,乙组采
目的:比较腹腔镜下肾囊肿去顶减压与彩超引导下囊肿穿刺术的治疗效果.方法:选取2016年01月到2017年06月本院接收的56例肾囊肿患者为研究对象,随机分为两组,各28例,对照组行腹
随着我国经济规模的扩大,教育行业的发展也提出了更好的要求。本文将会以高职院校的体育专业为研究对象,了解其教学过程中存在的问题,并以就业为导向提出有效的教学改革策略,
目的:评估妊娠糖尿病患者实施营养均衡饮食疗法的应用价值.方法:针对68例本医院诊治的妊娠糖尿病患者纳入实验资料,2019年2月至2020年2月是抽取时间,以抽签法对患者分成实验